BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31066863)

  • 1. Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria.
    Lancellotti P; Musumeci L; Jacques N; Servais L; Goffin E; Pirotte B; Oury C
    JAMA Cardiol; 2019 Jun; 4(6):596-599. PubMed ID: 31066863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds.
    Moreira CS; Silva AC; Novais JS; Sá Figueiredo AM; Ferreira VF; da Rocha DR; Castro HC
    J Appl Microbiol; 2017 Mar; 122(3):651-662. PubMed ID: 27930849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of antimicrobial activities of antibiotic-treated penile prostheses.
    Mansouri MD; Boone TB; Darouiche RO
    Eur Urol; 2009 Dec; 56(6):1039-45. PubMed ID: 19135292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.
    Gradelski E; Kolek B; Bonner DP; Valera L; Minassian B; Fung-Tomc J
    Int J Antimicrob Agents; 2001 Feb; 17(2):103-7. PubMed ID: 11165113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coriander essential oil and linalool - interactions with antibiotics against Gram-positive and Gram-negative bacteria.
    Aelenei P; Rimbu CM; Guguianu E; Dimitriu G; Aprotosoaie AC; Brebu M; Horhogea CE; Miron A
    Lett Appl Microbiol; 2019 Feb; 68(2):156-164. PubMed ID: 30471142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002].
    Eta S; Kawahara M
    Jpn J Antibiot; 2006 Feb; 59(1):21-8. PubMed ID: 16673579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction.
    Ji C; Lin W; Moraski GC; Thanassi JA; Pucci MJ; Franzblau SG; Möllmann U; Miller MJ
    Bioorg Med Chem; 2012 Jun; 20(11):3422-8. PubMed ID: 22560837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
    Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
    Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
    Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy.
    Tascini C; Piaggesi A; Tagliaferri E; Iacopi E; Fondelli S; Tedeschi A; Rizzo L; Leonildi A; Menichetti F
    Diabetes Res Clin Pract; 2011 Oct; 94(1):133-9. PubMed ID: 21824673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
    Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
    J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.
    Novais JS; Moreira CS; Silva ACJA; Loureiro RS; Sá Figueiredo AM; Ferreira VF; Castro HC; da Rocha DR
    Microb Pathog; 2018 May; 118():105-114. PubMed ID: 29550501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
    Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial action of a heat-stable form of L-amino acid oxidase isolated from king cobra (Ophiophagus hannah) venom.
    Lee ML; Tan NH; Fung SY; Sekaran SD
    Comp Biochem Physiol C Toxicol Pharmacol; 2011 Mar; 153(2):237-42. PubMed ID: 21059402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of vascular graft infections with antibiotic graft impregnation prior to implantation: in vitro comparison between daptomycin, rifampin and nebacetin.
    Bisdas T; Beckmann E; Marsch G; Burgwitz K; Wilhelmi M; Kuehn C; Haverich A; Teebken OE
    Eur J Vasc Endovasc Surg; 2012 Apr; 43(4):448-56. PubMed ID: 22264589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.